Last week United Therapeutics Corporation agreed t
Post# of 72440
Quote:
Last week United Therapeutics Corporation agreed to sell its Priority Review Voucher to AbbVie for $350 Million
- See more at: http://cellceutix.com/cellceutix-requesting-m...AAKXa.dpuf